PAVmed (PAVM) EPS (Basic) (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,803.45% |
| Sep 30, 2025 | 60.81% |
| Jun 30, 2025 | -157.81% |
| Mar 31, 2025 | -98.66% |
| Jun 30, 2024 | 54.58% |
| Mar 31, 2024 | -35.75% |
| Dec 31, 2023 | 18.91% |
| Sep 30, 2023 | -13.33% |
| Jun 30, 2023 | 24.46% |
| Mar 31, 2023 | 80.49% |
| Dec 31, 2022 | -4,813.79% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -45.00% |
| Mar 31, 2022 | 16.67% |
| Dec 31, 2021 | -60.00% |
| Sep 30, 2021 | -7.14% |
| Jun 30, 2021 | -7.69% |
| Mar 31, 2021 | 18.75% |
| Dec 31, 2020 | -45.45% |
| Sep 30, 2020 | 8.33% |
| Jun 30, 2020 | 63.64% |
| Mar 31, 2020 | -73.68% |
| Dec 31, 2019 | -90.00% |
| Sep 30, 2019 | 23.08% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 53.57% |
| Dec 31, 2018 | -133.33% |
| Sep 30, 2018 | 53.85% |
| Jun 30, 2018 | -52.94% |
| Mar 31, 2018 | -342.86% |
| Dec 31, 2017 | 118.42% |
| Sep 30, 2017 | -375.00% |
| Jun 30, 2017 | 75.00% |
| Mar 31, 2017 | -146.15% |
| Dec 31, 2016 | 7.14% |
| Sep 30, 2016 | -40.00% |
| Jun 30, 2016 | -66.67% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | -20.00% |
| Sep 30, 2015 | -66.67% |
| Jun 30, 2015 | -200.00% |